Ofer Mandelboim
Overview
Explore the profile of Ofer Mandelboim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
10831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zaffran I, Landolina N, Gaur P, Lenac Rovis T, Jonjic S, Mandelboim O, et al.
Cancer Gene Ther
. 2023 Feb;
30(6):926.
PMID: 36732550
No abstract available.
12.
Maalouf N, Gur C, Yutkin V, Scaiewicz V, Mandelboim O, Bachrach G
Front Cell Infect Microbiol
. 2022 Sep;
12:968739.
PMID: 36118038
Bladder cancer is the 4 leading cancer in men. Tumor resection followed by bladder instillation of Bacillus Calmette-Guérin (BCG) is the primary treatment for high-risk patients with Non-Muscle Invasive Bladder...
13.
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
Chaouat A, Brizic I, Kucan Brlic P, Atari N, Kliker L, Alfi O, et al.
iScience
. 2022 Aug;
25(9):104935.
PMID: 35992307
The global pandemic caused by SARS-CoV-2 is a major public health problem. Virus entry occurs via binding to ACE2. Five SARS-CoV-2 variants of concern (VOCs) were reported so far, all...
14.
Garces-Lazaro I, Kotzur R, Cerwenka A, Mandelboim O
Front Immunol
. 2022 Jun;
13:924775.
PMID: 35769460
Environmental conditions greatly shape the phenotype and function of immune cells. Specifically, hypoxic conditions that exist within tissues and organs have been reported to affect both the adaptive and the...
15.
Zaffran I, Landolina N, Gaur P, Lenac Rovis T, Jonjic S, Mandelboim O, et al.
Cancer Gene Ther
. 2022 Jun;
29(11):1676-1685.
PMID: 35681020
Inhibitory receptors (IRs), such as the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), are cell surface molecules expressed on both normal epithelial, endothelial, and hematopoietic cells and on neoplastic cells....
16.
Jasinski-Bergner S, Blumke J, Bauer M, Skiebe S, Mandelboim O, Wickenhauser C, et al.
Oncoimmunology
. 2022 May;
11(1):2070338.
PMID: 35529676
The human Epstein-Barr virus is associated with several human solid and hematopoietic malignancies. However, the underlying molecular mechanisms including virus-encoded microRNAs (miRs), which lead to the malignant transformation of infected...
17.
Charpak-Amikam Y, Lapidus T, Isaacson B, Duev-Cohen A, Levinson T, Elbaz A, et al.
Nat Commun
. 2022 May;
13(1):2463.
PMID: 35513379
Candida albicans is the most common fungal pathogen and a prevalent cause of deadly bloodstream infections. Better understanding of the immune response against it, and the ways by which it...
18.
Parhi L, Abed J, Shhadeh A, Alon-Maimon T, Udi S, Leviatan Ben-Arye S, et al.
Cell Rep
. 2022 Mar;
38(12):110537.
PMID: 35320712
While the existence of an indigenous placental microbiota remains controversial, several pathogens are known to be involved in adverse pregnancy outcomes. Fusobacterium nucleatum is an oral bacterium that is one...
19.
Kotzur R, Duev-Cohen A, Kol I, Reches A, Mandelboim O, Stein N
PLoS One
. 2022 Mar;
17(3):e0264897.
PMID: 35294457
NK-92 cells are an off-the-shelf, cell-based immunotherapy currently in clinical trials for a variety of cancer types. As the most 'NK-like' cell line available, it is also an important research...
20.
Alon-Maimon T, Mandelboim O, Bachrach G
Periodontol 2000
. 2022 Mar;
89(1):166-180.
PMID: 35244982
Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. ...